|
FBXO4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.123200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.910110E-02 |
| Normal-vs-Stage2 |
3.535000E-01 |
| Normal-vs-Stage3 |
9.670200E-02 |
| Normal-vs-Stage4 |
5.600400E-02 |
| Stage1-vs-Stage2 |
7.261000E-01 |
| Stage1-vs-Stage3 |
7.434800E-01 |
| Stage1-vs-Stage4 |
1.826780E-01 |
| Stage2-vs-Stage3 |
6.408800E-01 |
| Stage2-vs-Stage4 |
2.357400E-01 |
| Stage3-vs-Stage4 |
3.829200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.783200E-03 |
| Normal-vs-AfricanAmerican |
8.676200E-02 |
| Normal-vs-Asian |
6.301400E-01 |
| Caucasian-vs-AfricanAmerican |
3.610400E-01 |
| Caucasian-vs-Asian |
7.568400E-01 |
| AfricanAmerican-vs-Asian |
9.942000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.816050E-03 |
| Normal-vs-Female |
9.523800E-01 |
| Male-vs-Female |
1.341700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.401550E-01 |
| Normal-vs-Extreme_Weight |
1.012170E-02 |
| Normal-vs-Obese |
1.082570E-01 |
| Normal-vs-Extreme_Obese |
1.697450E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.719400E-01 |
| Normal_Weight-vs-Obese |
9.864000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.349780E-01 |
| Extreme_Weight-vs-Obese |
3.734000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.860450E-01 |
| Obese-vs-Extreme_Obese |
1.497450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.200000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.153650E-01 |
| Normal-vs-Age(61-80Yrs) |
1.037920E-03 |
| Normal-vs-Age(81-100Yrs) |
5.055400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.937760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.295600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.197600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.673900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.850200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.834400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.821900E-03 |
| Normal-VS-Type2 PRCC |
7.849700E-02 |
| Normal-VS-KIRP CIMP |
1.04549999768722E-08 |
| Normal-VS-Unclassified PRCC |
2.883400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.329800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.58249999995908E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.102800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.045740E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.652000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.49219999999273E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.063630E-02 |
| Normal-vs-N1 |
3.064000E-02 |
| Normal-vs-N2 |
9.343500E-02 |
| N0-vs-N1 |
5.699800E-01 |
| N0-vs-N2 |
7.514400E-01 |
| N1-vs-N2 |
9.782200E-01 |
|
|
